Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas.
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Neurofibromatoses; Plexiform neurofibroma
- Focus Therapeutic Use
- 02 Jun 2017 Status changed from active, no longer recruiting to completed.
- 04 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Aug 2016.
- 07 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.